Clinical Trials Directory

Trials / Completed

CompletedNCT05309681

Salivary Melatonin Levels and Sleep Quality in Patients With Burning Mouth Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
University of Zagreb · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers

Summary

Burning mouth syndrome is an idiopathic condition characterized by symptoms burning and / or pain of the oral mucosa with an orderly clinical finding. So far not found a unique way of treatment. It is a diagnosis that impairs the quality of life of patients, and consequently it can affect the quality of sleep. Melatonin is a hormone secreted from pineal gland and regulates the day-night rhythm of man, and whose production in the body decreases aging. The level of melatonin in saliva correlates well with the level of melatonin in plasma, therefore they are advantages of determining from saliva painlessness and non-invasiveness of the procedure itself. The purpose of this study was to compare the level of melatonin in saliva and the quality of sleep with help of the Epworth Sleepiness Scale in patients with burning mouth syndrome and control groups of patients without subjective oral disorders and with an orderly clinical finding.

Conditions

Interventions

TypeNameDescription
OTHEREpworth's sleepiness scale; unstimulated saliva sampleUnstimulated saliva sample; Epworth's sleepiness scale

Timeline

Start date
2021-01-07
Primary completion
2021-07-18
Completion
2021-12-15
First posted
2022-04-04
Last updated
2022-05-25

Locations

1 site across 1 country: Croatia

Source: ClinicalTrials.gov record NCT05309681. Inclusion in this directory is not an endorsement.